Optimi Health is trading 5.4% lower at $3.36, with no clear company-specific catalyst identified for the October 14, 2026 decline. - Its latest listed release was an October 7 announcement about presenting at the ThinkEquity Conference; no release is listed for October 13 or 14. - The S&P 500 is down 0.60%, Nasdaq is down 0.84%, and biotech is down 2.01%. - These may be background pressures, but available evidence does not establish a direct cause for the stockβs move.